OpenLB
Open Library of Bioscience
Advanced Search
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
Mar, 2022;44 (3): 264-271.

Cervical Cancer Screening with HPV Testing: Updates on the Recommendation.

Carla Fabrine Carvalho, Julio Cesar Teixeira, Joana Froes Bragan��a, Sophie Derchain, Luiz Carlos Zeferino, Diama Bhadra Vale
Author Information
  1. Carla Fabrine Carvalho: Department of Obstetrics and Gynecology, Universidade Estadual de Campinas, Campinas, SP, Brazil. ORCID
  2. Julio Cesar Teixeira: Department of Obstetrics and Gynecology, Universidade Estadual de Campinas, Campinas, SP, Brazil. ORCID
  3. Joana Froes Bragan��a: Department of Obstetrics and Gynecology, Universidade Estadual de Campinas, Campinas, SP, Brazil. ORCID
  4. Sophie Derchain: Department of Obstetrics and Gynecology, Universidade Estadual de Campinas, Campinas, SP, Brazil. ORCID
  5. Luiz Carlos Zeferino: Department of Obstetrics and Gynecology, Universidade Estadual de Campinas, Campinas, SP, Brazil. ORCID
  6. Diama Bhadra Vale: Department of Obstetrics and Gynecology, Universidade Estadual de Campinas, Campinas, SP, Brazil. ORCID
PMID: 35170010 DOI: 10.1055/s-0041-1739314

Abstract

The present update is a reassessment of the 2018 'Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil' (Zeferino et al.)9, according to the changes observed in new international guidelines and knowledge updates. The most relevant and recent guidelines were assessed. Questions regarding the clinical practice were formulated, and the answers considered the perspective of the public and private sectors of the Brazilian health system. The review addressed risk-based strategies regarding age to start and stop screening, the use of cytology and colposcopy to support management decisions, treatment, follow-up strategies, and screening in specific groups, including vaccinated women. The update aims to improve the prevention of cervical cancer and to reduce overtreatment and the misuse of HPV testing.

References

  1. Cancer Causes Control. 2016 Jul;27(7):889-96 [PMID: 27255650]
  2. J Obstet Gynaecol. 2019 Jan;39(1):86-90 [PMID: 30229689]
  3. J Low Genit Tract Dis. 2020 Apr;24(2):132-143 [PMID: 32243308]
  4. Cochrane Database Syst Rev. 2017 Aug 10;8:CD008587 [PMID: 28796882]
  5. Gynecol Oncol. 1995 Aug;58(2):206-9 [PMID: 7622107]
  6. JAMA Oncol. 2017 Jun 01;3(6):833-837 [PMID: 27685805]
  7. Lancet Glob Health. 2016 Jul;4(7):e453-63 [PMID: 27340003]
  8. Rev Bras Ginecol Obstet. 2019 Oct;41(10):579-580 [PMID: 31658486]
  9. BJOG. 2021 Feb;128(3):573-582 [PMID: 32638462]
  10. Lancet Oncol. 2011 Jul;12(7):663-72 [PMID: 21684207]
  11. Int J Gynaecol Obstet. 2021 Jan;152(1):7-11 [PMID: 33128771]
  12. Cancer Cytopathol. 2013 Oct;121(10):576-81 [PMID: 23765869]
  13. Br J Cancer. 2012 Apr 24;106(9):1571-8 [PMID: 22441643]
  14. BMC Public Health. 2020 Apr 6;20(1):458 [PMID: 32252705]
  15. Eur J Public Health. 2018 Dec 1;28(6):1132-1138 [PMID: 29684144]
  16. Obstet Gynecol. 2018 Sep;132(3):725-735 [PMID: 30095780]
  17. Gynecol Oncol. 2014 Nov;135(2):292-6 [PMID: 25130677]
  18. J Low Genit Tract Dis. 2020 Apr;24(2):102-131 [PMID: 32243307]
  19. Gynecol Oncol. 2001 Jul;82(1):4-6 [PMID: 11426953]
  20. PLoS One. 2021 May 14;16(5):e0251688 [PMID: 33989331]
  21. Ethn Health. 2020 Apr;25(3):393-407 [PMID: 29347831]
  22. Rev Bras Ginecol Obstet. 2018 Jun;40(6):360-368 [PMID: 29874685]
  23. Papillomavirus Res. 2019 Jun;7:123-128 [PMID: 30885798]
  24. Gynecol Oncol. 2015 Feb;136(2):178-82 [PMID: 25579107]
  25. Br J Obstet Gynaecol. 1995 Jan;102(1):58-61 [PMID: 7833312]
  26. MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):415-420 [PMID: 33764964]
  27. J Clin Med. 2015 Jan 29;4(2):260-81 [PMID: 26239127]
  28. BJOG. 2016 Jan;123(1):59-66 [PMID: 26177672]
  29. Br J Cancer. 2013 Jul 9;109(1):35-41 [PMID: 23820257]
  30. Eur J Cancer. 2013 Oct;49(15):3262-73 [PMID: 23751569]
  31. Br J Cancer. 2020 Aug;123(4):510-517 [PMID: 32507855]
  32. Obstet Gynecol. 2016 Jan;127(1):e1-e20 [PMID: 26695583]
  33. J Natl Cancer Inst. 2014 Jul 18;106(8): [PMID: 25038467]
  34. Obstet Gynecol. 2008 Jun;111(6):1279-84 [PMID: 18515509]
  35. BMJ. 2016 Jul 28;354:i3633 [PMID: 27469988]
  36. Lancet. 2014 Feb 8;383(9916):524-32 [PMID: 24192252]
  37. Vaccine. 2012 Nov 20;30 Suppl 5:F88-99 [PMID: 23199969]
  38. Best Pract Res Clin Obstet Gynaecol. 2020 May;65:98-108 [PMID: 32291178]
  39. Curr Oncol Rep. 2014 Dec;16(12):416 [PMID: 25325935]
  40. CA Cancer J Clin. 2020 Sep;70(5):321-346 [PMID: 32729638]
  41. JAMA. 2018 Aug 21;320(7):674-686 [PMID: 30140884]
  42. Ann Intern Med. 2018 Jan 2;168(1):20-29 [PMID: 29181509]
  43. Nat Rev Dis Primers. 2016 Dec 01;2:16086 [PMID: 27905473]

MeSH Term

Colposcopy
Early Detection of Cancer
Female
Humans
Mass Screening
Papillomaviridae
Papillomavirus Infections
Pregnancy
Uterine Cervical Neoplasms
Vaginal Smears
Uterine Cervical Dysplasia
Journal Article
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.0updateCervicalCancerScreeningguidelinesregardingstrategiesscreeningHPVpresentreassessment2018'GuidelinesHPV-DNATestingBrazil'Zeferinoetal9accordingchangesobservednewinternationalknowledgeupdatesrelevantrecentassessedQuestionsclinicalpracticeformulatedanswersconsideredperspectivepublicprivatesectorsBrazilianhealthsystemreviewaddressedrisk-basedagestartstopusecytologycolposcopysupportmanagementdecisionstreatmentfollow-upspecificgroupsincludingvaccinatedwomenaimsimprovepreventioncervicalcancerreduceovertreatmentmisusetestingTesting:UpdatesRecommendation

Similar Articles

Cited By